arBtrage CAPITALIZING MARKETS — checking… Sign in Sign up
Calendar /

Elevance Health, Inc.

ELV Health Care Medical Specialities
$445.28
▲ +1.2% Today
as of Oct 22, 16:48 ET
Last 30 days +4.96% Sep 14 → Oct 22
$376.58 $395.03 $413.48 $431.92 $450.37 Sep 14 Sep 22 Sep 29 Oct 07 Oct 14 Oct 22
Open
$432.56
High
$449.95
Low
$431.67
Volume
$1M
Avg Vol
$2M
Mkt Cap
$87.7B
P/E (TTM)
21.38
Beta
—
52w High
$450.69
52w Low
$274.84
Div Yield
—
Shares Out
$217M

Recent Press Releases & News last 60 days · 25 items

lean bull ▲ 4 ● 21 ▼ 0
Oct 22 · 10:03 MT Newswires neutral
Morgan Stanley Adjusts Price Target on Elevance Health to $449 From $404
Oct 22 · 10:03 MT Newswires neutral
Jefferies Adjusts Price Target on Elevance Health to $510 From $450
Oct 22 · 10:03 MT Newswires neutral
Guggenheim Adjusts Price Target on Elevance Health to $485 From $460
▸ Show all 25 press releases & news Free account →

ELV earnings at a glance

The options market is pricing a move of about ±4.3% after the report, a range of roughly $426.24 to $464.32 from today's $445.28. Over its last 6 reports the stock rose the next day 3 times and fell 3, moving ±5.0% on average; after the most recent report on Jul 15, 2026 it moved -8.5%. That means options currently expect about the same movement than ELV has typically delivered. ELV beat the consensus EPS estimate in 4 of its last 6 reported quarters. Implied volatility is currently 36%. The share price of $445.28 sits near its 52-week high.

More Health Care stocks · All stocks · Earnings calendar

Overview

52-week range
$275
$451
97% of range
Avg surprise (last 6)
+10.6%
Avg reaction (last 6)
-2.3%
50% positive
Latest IV / EM
36%
EM ±4.3% · $400 · Oct 16

Earnings trends

EPS — actual vs estimate Actual Estimate
$3.10$5.47$7.84$10.21$12.58 Actual $8.30Actual $7.79Actual $5.45Actual $9.59Actual $9.85Actual $4.36Actual $11.97Est $11.97Actual $8.84Est $9.16Actual $6.03Est $4.98Actual $3.33Est $3.10Actual $12.58Est $10.68Actual $7.45Est $6.18 MarJunSepMarJunSepMar/2025Jun/2025Sep/20258K8KJun/2026
Revenue vs Net Income Revenue Net income
$0$13.3B$26.6B$39.9B$53.2B Sep 24Mar 25Jun 25Sep 25Mar 26Jun 26

Earnings history

DatePeriodActual EPSEstSurpriseYoY %ΔDay reactSource
Wed Jul 15, 2026Jun/2026 $7.45 $6.18 +20.6% -30.1% -8.5% earnings
Wed Apr 22, 20268K 2026-04-22 $12.58 $10.68 +17.8% — +0.0% earnings
Wed Jan 28, 20268K 2026-01-28 $3.33 $3.10 +7.4% — +5.9% earnings
Tue Oct 21, 2025Sep/2025 $6.03 $4.98 +21.1% — -1.2% earnings
Thu Jul 17, 2025Jun/2025 $8.84 $9.16 -3.5% — -12.2% earnings
Tue Apr 22, 2025Mar/2025 $11.97 $11.97 0.0% — +2.3% earnings
Mon Sep 30, 2024Sep 2024 $4.36 — — — — financials
Sun Jun 30, 2024Jun 2024 $9.85 — — — — financials
Sun Mar 31, 2024Mar 2024 $9.59 — — — — financials
Sat Sep 30, 2023Sep 2023 $5.45 — — — — financials
Fri Jun 30, 2023Jun 2023 $7.79 — — — — financials
Fri Mar 31, 2023Mar 2023 $8.30 — — — — financials

Financials

Income statement (quarterly)

MetricJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Revenue$50.47B$50.18B—$50.71B$49.78B$48.89B—$45.11B
Cost of revenue$5.49B$5.46B—$5.38B$5.29B$4.98B—$5.09B
Gross profit————————
Operating income$1.76B$2.09B—$1.29B$2.42B$3.17B—$1.41B
Net income$1.46B$1.76B—$1.19B$1.74B$2.18B—$1.02B
EPS (diluted)$6.71$8.00—$5.32$7.72$9.61—$4.36

Balance sheet (quarterly)

MetricJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Cash & equivalents$10.23B$9.66B$9.49B$8.71B$8.56B$7.50B$8.29B$7.87B
Inventory————————
Total current assets$67.18B$67.03B$63.00B$63.78B$63.32B$61.12B$58.94B$62.85B
Total assets$126.44B$125.83B$121.49B$122.75B$121.94B$119.72B$116.89B$116.53B
Long-term debt$30.67B$30.77B$30.80B$31.17B$28.18B$28.11B$29.22B$24.69B
Total liabilities$81.42B$81.78B$77.47B$78.67B$78.09B$77.10B$75.46B$72.65B
Total equity$44.88B$44.04B$43.88B$43.95B$43.85B$42.62B$41.31B$43.88B

Implied volatility — last 90 days

24%40%56%73%89% Jun 07 — IV 40% · EM ±5.5%Jun 08 — IV 38% · EM ±5.1%Jun 09 — IV 39% · EM ±4.9%Jun 10 — IV 34% · EM ±4.0%Jun 11 — IV 32% · EM ±3.6%Jun 12 — IV 32% · EM ±3.3%Jun 15 — IV 38% · EM ±2.8%Jun 16 — IV 40% · EM ±2.4%Jun 17 — IV 48% · EM ±2.0%Jun 19 — IV 37% · EM ±8.2%Jun 22 — IV 38% · EM ±7.9%Jun 23 — IV 38% · EM ±7.8%Jun 24 — IV 41% · EM ±8.3%Jun 25 — IV 39% · EM ±7.6%Jun 26 — IV 38% · EM ±7.4%Jun 29 — IV 45% · EM ±7.9%Jun 30 — IV 41% · EM ±7.1%Jul 01 — IV 41% · EM ±6.9%Jul 02 — IV 39% · EM ±6.2%Jul 03 — IV 40% · EM ±6.2%Jul 06 — IV 43% · EM ±6.0%Jul 07 — IV 54% · EM ±7.1%Jul 08 — IV 55% · EM ±6.9%Jul 09 — IV 61% · EM ±7.2%Jul 10 — IV 60% · EM ±6.7%Jul 13 — IV 85% · EM ±7.1%Jul 14 — IV 89% · EM ±6.5%Jul 15 — IV 57% · EM ±3.4%Jul 16 — IV 32% · EM ±1.3%Jul 20 — IV 35% · EM ±8.2%Jul 21 — IV 33% · EM ±7.7%Jul 22 — IV 32% · EM ±7.4%Jul 23 — IV 33% · EM ±7.5%Jul 24 — IV 33% · EM ±7.3%Jul 27 — IV 34% · EM ±7.1%Jul 28 — IV 33% · EM ±6.8%Jul 29 — IV 33% · EM ±6.6%Jul 30 — IV 32% · EM ±6.3%Jul 31 — IV 33% · EM ±6.3%Aug 03 — IV 33% · EM ±5.8%Aug 04 — IV 34% · EM ±5.8%Aug 05 — IV 35% · EM ±5.8%Aug 06 — IV 33% · EM ±5.3%Aug 07 — IV 32% · EM ±4.9%Aug 10 — IV 33% · EM ±4.6%Aug 11 — IV 33% · EM ±4.3%Aug 12 — IV 32% · EM ±4.0%Aug 13 — IV 32% · EM ±3.7%Aug 14 — IV 29% · EM ±3.3%Aug 17 — IV 38% · EM ±3.2%Aug 18 — IV 41% · EM ±3.0%Aug 19 — IV 35% · EM ±2.0%Aug 20 — IV 49% · EM ±2.0%Aug 24 — IV 29% · EM ±6.1%Aug 25 — IV 26% · EM ±5.4%Aug 26 — IV 27% · EM ±5.4%Aug 27 — IV 26% · EM ±5.1%Aug 28 — IV 27% · EM ±5.1%Aug 31 — IV 24% · EM ±4.3%Sep 01 — IV 31% · EM ±5.3%Sep 02 — IV 26% · EM ±4.4%Sep 03 — IV 25% · EM ±4.0%Sep 04 — IV 26% · EM ±4.0%Sep 07 — IV 29% · EM ±4.0%Sep 08 — IV 28% · EM ±3.7%Sep 09 — IV 31% · EM ±3.9%Sep 10 — IV 31% · EM ±3.6%Sep 11 — IV 30% · EM ±3.3%Sep 14 — IV 34% · EM ±2.8%Sep 15 — IV 39% · EM ±2.8%Sep 16 — IV 33% · EM ±1.9%Sep 17 — IV 67% · EM ±2.8%Sep 21 — IV 33% · EM ±6.9%Sep 22 — IV 31% · EM ±6.3%Sep 23 — IV 31% · EM ±6.2%Sep 24 — IV 29% · EM ±5.7%Sep 25 — IV 34% · EM ±6.4%Sep 28 — IV 35% · EM ±6.2%Sep 29 — IV 36% · EM ±6.2%Sep 30 — IV 37% · EM ±6.1%Oct 01 — IV 41% · EM ±6.6%Oct 02 — IV 35% · EM ±5.5%Oct 06 — IV 38% · EM ±5.0%Oct 07 — IV 38% · EM ±4.8%Oct 08 — IV 36% · EM ±4.3%

Sector peers

CI
The Cigna Group
$73.6B $315.88+3.0%
NTRA
Natera, Inc.
$57.0B $401.37-1.1%
HUM
Humana Inc.
$47.6B $420.97-1.5%
ILMN
Illumina, Inc.
$40.4B $269.40+0.6%
CNC
Centene Corporation
$32.1B $71.24+0.6%
LH
Labcorp Holdings Inc.
$25.3B $329.93+2.1%

ELV earnings FAQ

What is ELV's expected move for earnings?

Options currently price a move of about ±4.3%, or $19.04 per share either way from $445.28.

How does ELV stock usually react to earnings?

Across the last 6 reports the average next-day move was ±5.0%, up 3 times and down 3 times.

What is ELV's implied volatility?

ELV's at-the-money implied volatility is about 36% based on the latest options snapshot.

View on Nasdaq ↗
🔒 Preview mode. Create a free account to unlock the full earnings calendar, all panels, heatmaps, options flow, and screener.
Sign up free → Sign in